OncoLink Exclusive!: Gemcitabine and paclitaxel as first line therapy for metastatic breast cancer: A new standard

This article has been archived.
Please use for reference only.

Julia Draznin Maltzman, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 7 de junio del 2004

Translation for this article does not exist